Muscle degeneration without mechanical injury in sarcoglycan deficiency - Wikidata - wikimedia - TriplyDB

Muscle degeneration without mechanical injury in sarcoglycan deficiency

Muscle degeneration without mechanical injury in sarcoglycan deficiency

http://www.wikidata.org/entity/Q35630800

about

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle Sarcoglycan isoforms in skeletal muscle The Dystrophin Complex: Structure, Function, and Implications for Therapy SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy Sarcoglycans in muscular dystrophy.Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle.Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle.Mechanisms of muscle weakness in muscular dystrophy The molecular neuropathology of the muscular dystrophies: a review and update.Patterning, prestress, and peeling dynamics of myocytes.Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice Secondary coronary artery vasospasm promotes cardiomyopathy progression.Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.Phenotypic and immunohistochemical characterization of sarcoglycanopathies.Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects Mutation of delta-sarcoglycan is associated with Ca(2+) -dependent vascular remodeling in the Syrian hamster.The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins.The dystrophin-associated glycoprotein complex: what parts can you do without?Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.Therapy insight: cardiovascular complications associated with muscular dystrophies.Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice What do mouse models of muscular dystrophy tell us about the DAPC and its components?delta- and gamma-Sarcoglycan localization in the sarcoplasmic reticulum of skeletal muscle.Sarcoglycan complex in human normal and pathological prostatic tissue: an immunohistochemical and RT-PCR study.Disturbed trafficking of dystrophin and associated proteins in targetoid phenomena after chronic muscle denervation.Deficiency of alpha-sarcoglycan differently affects fast- and slow-twitch skeletal muscles.Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy

P2860

Q24317313-52DA2322-B369-4891-BA32-C1110357D478 Q24538577-DA8DC667-874B-4AB1-8D03-3944DA9D4441 Q28141128-A02D0F0D-57FD-4910-89C1-C4994EBF5273 Q30376293-760FF89D-993D-40F4-9FF6-BC5723D3367D Q30498086-1DF645B5-FCEA-4765-B0D5-C22B35F111C9 Q33840940-9F5EF61E-E3D1-4220-A483-4586541E095D Q33883334-3B36B387-64E2-4DAE-BDF9-B54DF3A534A7 Q33893451-F4505EF1-4BE5-4EB7-8489-7E38B87E0FDF Q33950716-D1D9244F-A570-45A5-B58D-8330E2917B6E Q34118949-76668AD6-16DB-41F1-8131-6BC9ED0BCA60 Q34184701-F9D42D1E-CDB4-434E-BB8E-792505183498 Q34200139-AA7CDD79-99E3-465D-87F1-223BE19B18E4 Q34465820-2363D87C-9533-41D8-9638-56A6F534AF74 Q34627033-5926CBA4-A316-4829-A164-9777678630BA Q34654773-331D6727-8175-4E96-BAD6-9F064BFF3808 Q35027817-B810DC60-DC89-42B7-81AC-ABB4EDA86AFC Q35096094-AEFC67F6-236B-4ED2-B5AF-6D9B2CB46E33 Q35169510-6906017C-4FC3-4A63-AD4C-01523885152F Q35232488-E9AA37CB-0421-4E5D-8721-F30F15587CCE Q35253089-FB52F295-4E91-4FEF-A7E4-21BEA884BDEB Q35577201-C5F3D5DD-C7EF-4F08-BAA6-98919EF568F4 Q35750080-EB578C9C-4D23-4643-BFCA-66DD9906F5B9 Q35758335-E85448EC-3C16-4513-AF61-61B88FCA2F64 Q35928235-B273549F-8615-4029-9114-DF0346F7459F Q35951680-E58997A4-8BD4-47DE-9B6B-20EAB3713E51 Q36126467-2985E4C9-56FF-4DF0-AA63-63E6EF8DE6B8 Q36266510-4352CF96-174B-435B-8264-528C974DD054 Q36283349-B4CE55A7-257D-48B8-81C2-84674EE6FB41 Q36304335-3900F2F7-9E05-48BE-8888-55E98AB1368F Q36676817-3B2E53EC-F0D7-4A17-B56D-48783ACEBD99 Q37128346-EC666E19-3646-4CB6-84C2-28B9C2852856 Q37257159-B061314C-79D9-4FAE-9799-94D46682C8C8 Q38255744-00D975C2-C370-41FD-9011-38F4884B40E4 Q43548166-F0D72E80-FE9B-4833-AE82-BF3A53F1A8CE Q43950529-1B9F57F4-338D-413F-820C-3C0D803A7B00 Q44919290-85761F9B-5B39-4623-9E0A-FAD7DF775900 Q46588754-15AFBEB6-FD02-40B0-80E4-D82168FC61D0 Q57973234-FAC70DAF-FD92-4C07-AB6B-973E54979FB5

P2860

Muscle degeneration without mechanical injury in sarcoglycan deficiency

http://www.wikidata.org/entity/Q35630800

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@ast

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@en

type

label

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@ast

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@en

prefLabel

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@ast

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@en

P1433

Q35630800-CBAE1D70-4A73-4757-A231-654330725206

P1476

Q35630800-00BAC1FF-CA22-45A1-A88B-6DD759474ACC

P2093

Q35630800-1B727225-5B5C-49A7-9154-9E237A76E324

Q35630800-46871B3E-DCE1-428F-980A-0418F7F6681D

Q35630800-7CBC11E7-398B-4453-BCA5-4435A4C27B22

Q35630800-A139448C-15D1-472E-B781-9205516B174E

Q35630800-DF7B63D0-032F-49AF-A0BD-F083FDB50B74

Q35630800-F9243183-ED1E-4869-B081-59B814D07D02

P2860

Q35630800-0933808C-3480-4748-8259-9AC49B1BF36A

Q35630800-0BA73D5E-8396-4233-9DDE-003EDD1F7E51

Q35630800-1015855D-1410-4527-9FD0-1779D99119C5

Q35630800-127466A3-0ACD-4F0A-979B-E52D4CBB59E9

Q35630800-14C09145-20F4-4ACD-A15C-CCAC06D4E023

Q35630800-18256403-1E80-4596-8638-0E1CDC953CCF

Q35630800-1DE1AA0A-2F20-4CAC-80F1-7F647BF45E04

Q35630800-1F176DE4-072E-409D-8EFB-0EB60C867D51

Q35630800-43C61C37-DE43-4B5B-81D5-602FB0216B04

Q35630800-46507842-A4BA-4589-8074-997D42699DB3

P304

Q35630800-0B0BE79B-A663-4D06-9950-76250C65E213

P31

Q35630800-EC1DA91F-6651-4A66-9AEC-29996E15C9F0

P356

Q35630800-775985F3-8AD4-4427-A241-CD123216156D

P407

Q35630800-B305F044-9BF1-4BCA-84DF-B2EB1F129B48

P433

Q35630800-48A60506-24E7-4C25-98C5-87B29DE257AD

P478

Q35630800-A2A72CAE-D51B-4BC2-B1A4-3C3120A85C8D

P577

Q35630800-2A4D523B-08F7-4C57-87E8-473D00C5EE57

P5875

Q35630800-9C6F3E9E-4E8D-4EBE-B3F4-10E01A588469

P698

Q35630800-784863A9-6F9D-4382-B98C-4D12A6B9C0B2

P932

Q35630800-B462C8FF-F512-4053-A17F-AE2DCA4B2E3D

P356

PNAS.96.19.10723

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Muscle degeneration without mechanical injury in sarcoglycan deficiency

@en

P2093

Cordier L

http://www.w3.org/2001/XMLSchema#string

Hack AA

http://www.w3.org/2001/XMLSchema#string

Lam MY

http://www.w3.org/2001/XMLSchema#string

McNally EM

http://www.w3.org/2001/XMLSchema#string

Shoturma DI

http://www.w3.org/2001/XMLSchema#string

Sweeney HL

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene

Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene

Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane

Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12

Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24

epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy

Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression

beta-dystrobrevin, a member of the dystrophin-related protein family

Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy

P304

10723-10728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.19.10723

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12814098

http://www.w3.org/2001/XMLSchema#string

P698

10485893

http://www.w3.org/2001/XMLSchema#string

P932

17950

http://www.w3.org/2001/XMLSchema#string